| __timestamp | ACADIA Pharmaceuticals Inc. | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 2704597 |
| Thursday, January 1, 2015 | 73869000 | 15470000 |
| Friday, January 1, 2016 | 99284000 | 28037000 |
| Sunday, January 1, 2017 | 149189000 | 71615000 |
| Monday, January 1, 2018 | 187163000 | 99828000 |
| Tuesday, January 1, 2019 | 240385000 | 166023000 |
| Wednesday, January 1, 2020 | 319130000 | 201727000 |
| Friday, January 1, 2021 | 239415000 | 259039000 |
| Saturday, January 1, 2022 | 361575000 | 294781000 |
| Sunday, January 1, 2023 | 351619000 | 344077000 |
Cracking the code
In the ever-evolving world of pharmaceuticals, innovation is key to staying ahead. Over the past decade, ACADIA Pharmaceuticals Inc. and Iovance Biotherapeutics, Inc. have demonstrated their commitment to research and development (R&D) with significant investments. From 2014 to 2023, ACADIA's R&D spending surged by nearly 480%, peaking in 2022. Meanwhile, Iovance's R&D expenses skyrocketed by an astonishing 12,600% during the same period, reflecting their aggressive pursuit of innovation.
In 2023, both companies reached a near parity in R&D spending, with ACADIA investing slightly more than $350 million and Iovance close behind. This trend highlights a growing emphasis on innovation as both companies strive to develop groundbreaking therapies. As the pharmaceutical landscape continues to shift, these investments underscore the critical role of R&D in driving future growth and success.
R&D Spending Showdown: Novartis AG vs ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Iovance Biotherapeutics, Inc.
Gilead Sciences, Inc. vs ACADIA Pharmaceuticals Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Regeneron Pharmaceuticals, Inc. and ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
Grifols, S.A. or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Ionis Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Analyzing R&D Budgets: CRISPR Therapeutics AG vs Iovance Biotherapeutics, Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. Allocate Funds
ACADIA Pharmaceuticals Inc. vs Galapagos NV: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Protagonist Therapeutics, Inc. and Iovance Biotherapeutics, Inc.